BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2306733)

  • 21. Modulation of proliferation, estradiol receptors and estrogen regulated protein PS2/BCEI in human breast cancer cell lines by gamma interferon.
    Solary E; Prud'homme JF; Gauville C; Magdelenat H; Calvo F
    J Biol Regul Homeost Agents; 1991; 5(3):98-106. PubMed ID: 1763658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the breast cancer-associated protein pS2 in adenosquamous carcinomas of the gastrointestinal tract.
    Welter C; Seitz G; Blin N
    Acta Oncol; 1993; 32(3):315-7. PubMed ID: 8323770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of pS2 protein in breast cancer.
    Crombach G; Ingenhorst A; Göhring UJ; Scharl A; Neuhaus W; Möbus V; Schaeffer HJ
    Arch Gynecol Obstet; 1993; 253(4):183-92. PubMed ID: 8161252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. pS2 is an independent factor of good prognosis in primary breast cancer.
    Thompson AM; Hawkins RA; Elton RA; Steel CM; Chetty U; Carter DC
    Br J Cancer; 1993 Jul; 68(1):93-6. PubMed ID: 8318427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormone-sensitive gene expression in breast tumours.
    Wysocki SJ; Hahnel E; Wilkinson SP; Smith V; Hahnel R
    Anticancer Res; 1990; 10(1):185-8. PubMed ID: 2334125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An immunohistochemical survey of pS2 expression in human epithelial cancers.
    Luqmani YA; Ryall G; Shousha S; Coombes RC
    Int J Cancer; 1992 Jan; 50(2):302-4. PubMed ID: 1730524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [pS2 protein and breast cancer].
    Torre EA; Fulco RA
    Minerva Ginecol; 1995 Dec; 47(12):553-6. PubMed ID: 8720977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of the pNR-2/pS2 protein in diverse human epithelial tumours.
    Henry JA; Bennett MK; Piggott NH; Levett DL; May FE; Westley BR
    Br J Cancer; 1991 Oct; 64(4):677-82. PubMed ID: 1911216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. pS2 expression and response to hormonal therapy in patients with advanced breast cancer.
    Schwartz LH; Koerner FC; Edgerton SM; Sawicka JM; Rio MC; Bellocq JP; Chambon P; Thor AD
    Cancer Res; 1991 Jan; 51(2):624-8. PubMed ID: 1985778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the estrogen-induced pS2 protein secreted by the human breast cancer cell line MCF-7.
    Nunez AM; Jakowlev S; Briand JP; Gaire M; Krust A; Rio MC; Chambon P
    Endocrinology; 1987 Nov; 121(5):1759-65. PubMed ID: 3665845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. pS2 protein status fails to be an independent prognostic factor in an average breast cancer population.
    Speiser P; Stolzlechner J; Haider K; Heinzl H; Jakesz R; Pecherstorfer M; Rosen H; Sevelda P; Zeilliger R
    Anticancer Res; 1994; 14(5B):2125-30. PubMed ID: 7840511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance.
    Kohler M; Janz I; Wintzer HO; Wagner E; Bauknecht T
    Anticancer Res; 1989; 9(6):1537-47. PubMed ID: 2697181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulation of pS2 expression by diet-derived compounds.
    Sathyamoorthy N; Wang TT; Phang JM
    Cancer Res; 1994 Feb; 54(4):957-61. PubMed ID: 8313386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzyme immunoassay and Scatchard plot estimation of estrogen receptor in gynecological tumors.
    Spona J; Gitsch E; Kubista E; Salzer H; Köhler B
    Cancer Res; 1986 Aug; 46(8 Suppl):4310s-4312s. PubMed ID: 2425949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen and progesterone receptors and pS2 and ERD5 antigens in gastric carcinomas from the European population.
    Chaubert P; Bouzourene H; Saraga E
    Mod Pathol; 1996 Mar; 9(3):189-93. PubMed ID: 8685212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. pS2 protein in gastric carcinoma and normal gastric mucosa: association with clincopathological parameters and patient survival.
    Müller W; Borchard F
    J Pathol; 1993 Dec; 171(4):263-9. PubMed ID: 8158455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular and molecular events in loss of estrogen sensitivity in ZR-75-1 and T-47-D human breast cancer cells.
    Daly RJ; Darbre PD
    Cancer Res; 1990 Sep; 50(18):5868-75. PubMed ID: 2393857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of oestrogen receptor and oestrogen-inducible genes pS2 and ERD5 in large bowel mucosa and cancer.
    Singh S; Poulsom R; Hanby AM; Rogers LA; Wright NA; Sheppard MC; Langman MJ
    J Pathol; 1998 Feb; 184(2):153-60. PubMed ID: 9602706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CAM26 cytosol levels seem to be correlated with pS2 expression in breast cancer.
    Fernandez Fernandez M; Fernandez Llana B; Fernandez Raigoso P; Roiz MC; Allende MT; Ruibal A
    Int J Biol Markers; 1993; 8(1):25-6. PubMed ID: 8496628
    [No Abstract]   [Full Text] [Related]  

  • 40. The mouse one P-domain (pS2) and two P-domain (mSP) genes exhibit distinct patterns of expression.
    Lefebvre O; Wolf C; Kédinger M; Chenard MP; Tomasetto C; Chambon P; Rio MC
    J Cell Biol; 1993 Jul; 122(1):191-8. PubMed ID: 8314841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.